Cargando…
Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea
In South Korea, the ready-to-use hexavalent vaccine (against diphtheria, tetanus, pertussis, poliovirus, Haemophilus influenzae type b, and hepatitis B) is not listed despite its facility of no need to reconstitute. It, therefore, has the potential to augment the efficiency of prevention against the...
Autores principales: | Min, Serim, Kwon, Sun-Hong, Lee, Yeon-Woo, Lee, Jung-Min, Bae, Eun Jin, Lee, Eui-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221495/ https://www.ncbi.nlm.nih.gov/pubmed/37243088 http://dx.doi.org/10.3390/vaccines11050984 |
Ejemplares similares
-
Cost effectiveness of a pentavalent rotavirus vaccine in Oman
por: Al Awaidy, Salah Thabit, et al.
Publicado: (2014) -
Infant vaccination against pertussis in Argentina: Parent-reported outcomes on reactogenicity, impact on daily routine and satisfaction after pentavalent whole-cell or hexavalent acellular pertussis vaccines
por: Gentile, Angela, et al.
Publicado: (2023) -
Cost minimization analysis of a hexavalent vaccine in Argentina
por: Olivera, Ignacio, et al.
Publicado: (2023) -
Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea
por: Yun, Jae-Won, et al.
Publicado: (2019) -
Immunogenicity and Complications of the Pentavalent Vaccine in Iranian Children
por: Ekrami Noghabi, Mina, et al.
Publicado: (2021)